Volume 22, Number 10—October 2016
Research
Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples
Table 2
Isolate no. |
Test isolate |
Resistance profile
of wild type |
Resistance profile
of transconjugant |
MIC IPM, μg/mL† |
Frequency of transfer |
J53-Na-Azide | Escherichia coli | – | AMP, CRO, SXT, CXM, CTX | 3 | 8.7 × 105 |
BCH 04216 | EAEC | AMP, ERY, SXT, NA, CXM, CTX | AMP, E, SXT, NA, CXM, CTX, CRO | 3 | 5.9 × 105 |
IDH 04184 | EPEC | AMP, ERY, OFX, NOR, SXT, NA, CIP | AMP, E, OFX, NOR, SXT, NA, CIP, CRO, CXM, CTX | 1.5 | 2.7 × 105 |
IDH 06412 | ETEC | AMP, ERY, NA, SXT | AMP, E, NA, SXT, CRO, CXM, CTX | 3 | 7.5 × 105 |
BCH 0704 | Salmonella Bareilly | – | AMP, CRO, SXT, CXM, CTX | 3 | 1.7 × 103 |
570764 | Salmonella Newport | – | AMP, CRO, SXT, CXM, CTX | 3 | 1.4 × 103 |
IDH 06370 | Shigella dysenteriae 12 | AMP, STR, NA | AMP, STR, NA, CRO, SXT, CXM, CTX | 1.5 | 2.4 × 103 |
IDH 06498 | Shigella flexneri 4 | AMP, E, STR, SXT | AMP, E, STR, SXT, CRO, CXM, CTX | 3 | 4.4 × 103 |
IDH 06342 | Shigella flexneri 1b | AMP, E, NA, STR, SXT | AMP, E, NA, STR, SXT, CRO, CXM, CTX | 0.75 | 1.9 × 103 |
IDH 03988 | V. parahaemolyticus | AMP | AMP, CRO, SXT, CXM, CTX | 0.50 | 5.7 × 105 |
*Antibiogram in bold among transconjugants denote acquired resistance phenotypes from V. fluvialis IDH05720 after conjugation. AMP, ampicillin; CIP, ciprofloxacin; CRO, ceftriaxone; CTX, cefotaxime; CXM, cefuroxime; EAEC, enteroaggressive E. coli; EPEC, enteropathogenic E. coli; ERY, erythromycin; ETEC, enterotoxigenic E. coli; NA, nalidixic acid; NDM-1, New Delhi metallo-β-lactamase; NOR, norfolxacin; OFX, ofloxacin; STR, streptomycin, SXT, sulfamethoxxozole.
†MIC for imepenium. MIC denotes values of imepenium across different pathogens that were used as transconjugants.
Page created: September 19, 2016
Page updated: September 19, 2016
Page reviewed: September 19, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.